File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Endothelium-derived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat

TitleEndothelium-derived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat
Authors
KeywordsCyclooxygenase
Endothelium-derived contracting factor
Endothelium-derived relaxing factor
Serotonin
Spontaneously hypertensive rat
Issue Date1991
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/amjhyper
Citation
American Journal Of Hypertension, 1991, v. 4 n. 9, p. 769-772 How to Cite?
AbstractContractions to serotonin are augmented in aortas with endothelium from spontaneously hypertensive rats (SHR) compared to normotensive controls (WKY). Experiments were designed to determine whether this is due to the release of a vasoconstrictor prostanoid from the endothelium. Rings of aortas with and without endothelium were taken from SHR and WKY and suspended in organ chambers for isometric tension recording. Contractions to serotonin were similar in rings without endothelium from both strains. The presence of the endothelium reduced the contractions to all concentrations of serotonin in the WKY; in the SHR the endothelium inhibited only the response to lower concentrations of serotonin. Indomethacin (or meclofenamate) reduced the contractions to high concentrations of serotonin only in rings from SHR with endothelium; it did not affect the response in SHR rings without endothelium or in rings from WKY (with and without endothelium). The endothelium inhibited contractions to norepinephrine only in the presence of indomethacin in both strains. These experiments suggest that serotonin stimulates the release of vasoconstrictor prostanoids from the endothelium of the SHR but not from the WKY aorta. Norepinephrine may release endothelium-derived contracting factor(s) in both strains.
Persistent Identifierhttp://hdl.handle.net/10722/171014
ISSN
2023 Impact Factor: 3.2
2023 SCImago Journal Rankings: 0.925
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorAuchSchwelk, Wen_US
dc.contributor.authorVanhoutte, PMen_US
dc.date.accessioned2012-10-30T06:11:50Z-
dc.date.available2012-10-30T06:11:50Z-
dc.date.issued1991en_US
dc.identifier.citationAmerican Journal Of Hypertension, 1991, v. 4 n. 9, p. 769-772en_US
dc.identifier.issn0895-7061en_US
dc.identifier.urihttp://hdl.handle.net/10722/171014-
dc.description.abstractContractions to serotonin are augmented in aortas with endothelium from spontaneously hypertensive rats (SHR) compared to normotensive controls (WKY). Experiments were designed to determine whether this is due to the release of a vasoconstrictor prostanoid from the endothelium. Rings of aortas with and without endothelium were taken from SHR and WKY and suspended in organ chambers for isometric tension recording. Contractions to serotonin were similar in rings without endothelium from both strains. The presence of the endothelium reduced the contractions to all concentrations of serotonin in the WKY; in the SHR the endothelium inhibited only the response to lower concentrations of serotonin. Indomethacin (or meclofenamate) reduced the contractions to high concentrations of serotonin only in rings from SHR with endothelium; it did not affect the response in SHR rings without endothelium or in rings from WKY (with and without endothelium). The endothelium inhibited contractions to norepinephrine only in the presence of indomethacin in both strains. These experiments suggest that serotonin stimulates the release of vasoconstrictor prostanoids from the endothelium of the SHR but not from the WKY aorta. Norepinephrine may release endothelium-derived contracting factor(s) in both strains.en_US
dc.languageengen_US
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/amjhyperen_US
dc.relation.ispartofAmerican Journal of Hypertensionen_US
dc.subjectCyclooxygenase-
dc.subjectEndothelium-derived contracting factor-
dc.subjectEndothelium-derived relaxing factor-
dc.subjectSerotonin-
dc.subjectSpontaneously hypertensive rat-
dc.subject.meshAnimalsen_US
dc.subject.meshAorta - Metabolism - Ultrastructureen_US
dc.subject.meshCyclooxygenase Inhibitors - Pharmacologyen_US
dc.subject.meshDose-Response Relationship, Drugen_US
dc.subject.meshEndothelium, Vascular - Metabolism - Ultrastructureen_US
dc.subject.meshHypertension - Metabolism - Physiopathologyen_US
dc.subject.meshIndomethacin - Pharmacologyen_US
dc.subject.meshNorepinephrine - Pharmacologyen_US
dc.subject.meshProstaglandins - Pharmacologyen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, Inbred Shr - Physiologyen_US
dc.subject.meshRats, Inbred Strainsen_US
dc.subject.meshRats, Inbred Wkyen_US
dc.subject.meshReceptors, Cell Surface - Metabolismen_US
dc.subject.meshReceptors, Endothelinen_US
dc.subject.meshSerotonin - Pharmacologyen_US
dc.subject.meshVasoconstriction - Drug Effects - Physiologyen_US
dc.titleEndothelium-derived contracting factor released by serotonin in the aorta of the spontaneously hypertensive raten_US
dc.typeArticleen_US
dc.identifier.emailVanhoutte, PM:vanhoutt@hku.hken_US
dc.identifier.authorityVanhoutte, PM=rp00238en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1093/ajh/4.9.769-
dc.identifier.pmid1657042-
dc.identifier.scopuseid_2-s2.0-0025915807en_US
dc.identifier.volume4en_US
dc.identifier.issue9en_US
dc.identifier.spage769en_US
dc.identifier.epage772en_US
dc.identifier.isiWOS:A1991GE61100007-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridAuchSchwelk, W=7003395589en_US
dc.identifier.scopusauthoridVanhoutte, PM=7202304247en_US
dc.identifier.issnl0895-7061-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats